Skip to main content
menu
URochester Medicine / Department of Biostatistics and Computational Biology / People & Research / Faculty / Derick Peterson, PhD

Derick Peterson, PhD

Derick Peterson, PhDProfessor of Biostatistics and Computational Biology
 Professor of Oncology
Co-Director, Biostatistics and Bioinformatics Shared Resource for the Wilmot Cancer Institute

Contact Information:

University of Rochester
Dept of Biostatistics and Computational Biology
265 Crittenden Boulevard, CU 420630
Rochester, New York 14642-0630
 
Office: Saunders Research Building 4132
Phone: (585) 275-6686
E-mail: Derick_Peterson (at) urmc.rochester.edu

Research Interests

Methodological research topics of particular interest to me include the construction of prognostic gene expression profiles from high-dimensional transcriptomic data, model selection, nonparametric estimation and inference, data-driven smoothing methods, and the analysis of censored survival data. 

My experience in applied medical & epidemiological research has focused on cancer, cardiology, and infectious respiratory diseases. 

I joined the Biostatistics faculty at the University of Rochester in 1998, directly after receiving my PhD in Biostatistics from UC-Berkeley, under the supervision of Prof. Mark J. van der Laan and Prof. Kjell A. Doksum.

Technical reports

  • Peterson, D. (2006). Constructing Multivariate Prognostic Gene Signatures with Censored Survival Data. (Technical Report 06/09).

Selected Publications

  • Shune L, Qasrawi A, Hildebrandt G, Huselton E, Langstein H, Allin D, Baran A, Liesveld JL, Blumberg N, Lipe B, Evans A, Peterson D, and Aljitawi OS (2026). Incorporating Hyperbaric Oxygen into Autologous HSPCT for Multiple Myeloma: A Phase II Clinical Trial. Hematological Oncology (HO-4617610 submitted 9/21/2026).
  • Lipe B, Huselton E, Louie T, Baran A, Blumberg N, Evans A, Peterson D, Liesveld JL, and Aljitawi OS (2026). Safety and Tolerability of Multiple Hyperbaric Oxygen Treatments Incorporated into Standard Autologous HSPCT for Multiple Myeloma. British Journal of Haematology (submitted 9/10/2026).
  • Zareba W, Gasperetti A, Tichnell C, Rosero SZ, Cerrone M, Zipse MM, Marchlinski FE, Sun AY, Indik JH, Cutter K, James CA, Peterson DR, Mestroni L, Polonsky B, Brown M, Murray B, Jankelson L, Daubert JP, Haigney MC, Needleman M, Oakes D, Delmar M, CalkinsH (2026). Randomized Placebo-Controlled Trial of Flecainide in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy. JACC: Clinical Electrophysiology (to appear).
  • Falsey AR, Peterson DR, Baran AM, Walsh EE, Bhattacharya S, Branche AR, Croft DP, Mariani TJ (2026). Discriminating Bacterial from Nonbacterial Lower Respiratory Tract Infection within Clinical Subgroups of Hospitalized Adults. Journal of Infectious Diseases 2026, jiag297, https://doi.org/10.1093/infdis/jiag297.
  • Cubello J, Ambeskovic A, Salois G, Wang L, Peterson DR, Proschel C, Mayer-Proschel M (2026). Postnatal Iron Supplementation Fails to Fully Rescue Brain Metal and Transcriptional Defects Caused by Nutrition-Based Gestational Iron Deficiency. The Journal of NutritionVolume

    156, Issue 9, September 2026, 101730. https://doi.org/10.1016/j.tjnut.2026.101730

  • Croft DP, Islam MR, Thevenet-Morrison K, Johnston CJ, Utell MJ, Hopke PK, Georas S, Litonjua A, Peterson D, Bhattacharya S, Baran A, Chu C, Corbett A, Peasley M, Branche AR, Walsh EE, McCall MN, Thurston SW, Falsey AR, Mariani T, Rich DQ (2026). Triggering of viral and bacterial respiratory infection hospitalizations by traffic pollution exposure in a cohort of hospitalized adults. PLoS One21(7): e0352323.

    https://doi.org/10.1371/journal.pone.0352323.

  • Samoriski C, Chu C-Y, Falsey AR, Peterson DR, Bhattacharya S, Croft DP, Branche AR, Peasley M, Baran A, Corbett A, Ashton J, Mariani TJ,Walsh EE (2025). Clinical Features and Gene Expression Patterns in Adults Hospitalized with Respiratory Syncytial Virus (RSV) and Human  Metapneumovirus (HMPV) Infection. Journal of Infectious Diseases Jul 16;232(Supplement 1):S37–S46. PMID: 40668099 PMCID: PMC12265063 DOI: 10.1093/infdis/jiaf084
  • Peterson DR, Baran AM, Bhattacharya S, Branche AR, Croft DP, Corbett AM, Walsh EE, Falsey AR, Mariani TJ (2023). Gene Expression Risk Scores for COVID-19 Illness Severity. Journal of Infectious Diseases 227:322–331. doi: 10.1093/infdis/jiab568. PMID: 34850892.

    PMCID: PMC8767880.

  • Wang M, Peterson DR, Pagan E, Bagnardi V, Mazzanti A, McNitt S, Rich DQ, Seplaki CL, Kutyifa V, Polonsky B, Barsheshet A, Kukavica D, Rosero S, Goldenberg I, Priori SG, Zareba W (2022). Assessment of absolute risk of life-threatening cardiac events in Long QT Syndrome patients. Frontiers in Cardiovascular Medicine, section Cardiac Rhythmology
  • Steinberg J, Gorcsan J, Mazur A, Jain SK, Rashtian M, Greer GS, Zarraga I, Vloka M, Cook MM, Salam T, Mountantonakis S, Beck H, Silver J, Aktas M, Henrikson C, Schaller RD, Epstein AE, McNitt S, Schleede S, Peterson D, Goldenberg I, Zareba W (2022). Junctional AV ablation in patients with atrial fibrillation undergoing cardiac resynchronization therapy (JAVA-CRT): results of a multicenter randomized clinical trial pilot program. Journal of Interventional Cardiac Electrophysiology 2022 Jan 18:112. doi: 10.1007/s10840-021-01116-6. Epub ahead of print. PMID: 35043250; PMCID: PMC8765764.
  • Pinney JJ, Blick-Nitko SK, Baran AM, Peterson DR, Whitehead HE, Izumi R, Munugalavadla V, VanDerMeid KR, Barr PM, Zent CS, Elliott MR, Chu CC (2022). The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact. Haematologica 2022 Feb 17. doi: 10.3324/haematol.2021.279560. Epub ahead of print. PMID: 35172559.
  • Mazzanti A, Trancuccio A, Kukavica D, Pagan E, Wang M, Mohsin M, Peterson D, Bagnardi V, Zareba W, Priori SG (2022). Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors’ reply. Europace. 2022 Apr 5;24(4):698-699. doi: 10.1093/europace/euac013. PMID: 35303087.